Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Australia invests AUSD 4 mn for research with India on COVID-19
Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus…
FDA Advisory Committee supports EUA of Pfizer-BioNTech COVID-19 vaccine in US
FDA Advisory Committees provide non-binding recommendations, with the final decision on approval or authorisation to be made by…
IPA to train 10 lakh pharmacists for COVID-19 vaccinations
The association has asked its 22 state branches to identify five thousand registered pharmacists each for training with an aim to…
Gilead Sciences to acquire MYR GmbH
Gilead to acquire Hepcludex, a first-in-class entry inhibitor, for treatment of chronic hepatitis delta virus (HDV), after closing…
Moderna announces dosing of first adolescent participants in Phase II-III trials of COVID-19 vaccine
Phase II-III trials are expected to enrol 3,000 healthy participants
Indian researchers find new potential COVID-19 drug treatments
One proposed cocktail, baloxavir marboxil, natamycin and RU85053, targets the three viral proteins respectively, 3CL Main…
SeQuent launches Citramox LA in ten European countries
It is an antibiotic indicated for the treatment of respiratory infections caused by Mannheimia haemolytica and Pasteurella…
Snowman Logistics and Spicejet sign MoU for COVID-19 vaccines distribution
Snowman will handle the ground services while Spicejet provide the air connectivity for temperature-controlled distribution,…
Biogen applies for approval of Alzheimer’s drug, aducanumab in Japan
Biogen and Eisai have jointly developed three experimental drugs for Alzheimer’s
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine
Pfizer and BioNTech said they were supporting the MHRA’s investigation